Stock Market - Intrinsic Valuez

Cytokinetics Stock Soars 40% After Breakthrough Heart Drug Trial Success

September 2, 2025 by IntrinsicValuez

After positive news about a new heart medicine, the price of Cytokinetics stock goes up by more than 40%. Shares of Cytokinetics (CYTK) rose more than 40% today after the firm showed off very positive clinical trial findings for its cardiac medication aficamten at the European Society of Cardiology Congress. What happened and why it … Read more

Ambarella Stock Surges Nearly 17% After Stellar Q2 Earnings Beat and Bullish AI Growth Outlook

September 5, 2025August 31, 2025 by IntrinsicValuez

Chipmaker’s revenue jumps nearly 50%, driving raised guidance and fueling investor excitement in edge AI semiconductor market. What happened & why it matters On August 29, 2025, shares of Ambarella Inc. (NASDAQ: AMBA) went up almost 17% after the company said that its second-quarter results for fiscal 2026 were higher than expected and that it … Read more